News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vascular Nanotransfer Technologies (“VNT”) Reports In Vivo Results for Its Paclitaxel Nano-Carrier Based Drug Coated Balloon (DCB) Technology


10/26/2012 8:00:12 AM

AUBURNDALE, Mass.--(BUSINESS WIRE)--Vascular Nanotransfer Technologies (“VNT”) (www.vnanotech.com), an emerging medical technology company, announced today that large animal model in vivo tests of its paclitaxel nanocarrier-based Drug Coated Balloon (“DCB”) achieved tissue levels comparable to devices with proven clinical efficacy.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES